# Semble Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/semble-technology

- Industry: Healthcare IT
- Headquarters: London, UK
- Website: www.semble.io
- Total disclosed funding: $68M
- Latest round: Series C (Jun 4, 2026)
- Investors on record: 9

## About

Based in London, UK, and founded in 2016 by its CEO Christoph Lippuner, and CTO, Mikael Landau, Semble Technology Limited, formerly known as Heydoc, operates as a healthcare technology company that develops software to cater the needs of healthcare businesses of all sizes, ranging from individual clinicians to large enterprises. In June 2026, Semble Technology Limited raised GBP 30 million in series C funding led by Revaia, with participation from Partech Partners, Mercia Asset Management and Octopus Investments.

Semble Technology Limited offers a comprehensive suite of tools that enable personalized care and patient engagement. The company automates the booking process and streamlines patient intake, enabling access to care, automates personalized communications, and remote consultations via Semble Telehealth, and provides unparalleled insights into financial, operational, and patient data with analytics. Additionally, the platform streamlines the billing process and ensure timely payments with invoicing and payment module.  The company's client base includes One Welbeck, GPDQ, and London Doctor Clinic.

The company will use the June 2026 funding to expand its presence across Europe, scale its AI care orchestration platform, and grow its customer base.

## Funding rounds

- Series C, Jun 4, 2026, $40M — Partech Partners, Mercia Asset Management, Octopus Investments, Revaia
- Series B, Oct 7, 2024, $16M — Smedvig Capital, Mercia Asset Management, TriplePoint Capital, Octopus Investments
- Series A, Aug 18, 2021, $8.2M — Smedvig Capital, Salica Investments, InHealth Ventures, Triple Point Investment Management
- Seed, Nov 20, 2019, $2.2M — TriplePoint Capital, Salica Investments, InHealth Ventures
- Seed, Jan 16, 2018, $1.6M — Salica Investments, InHealth Ventures

## Investors

- Salica Investments (https://capitalatlas.ai/funds/salica-investments) — Seed, Series A
- InHealth Ventures (https://capitalatlas.ai/funds/inhealth-ventures) — Seed, Series A
- TriplePoint Capital (https://capitalatlas.ai/funds/triplepoint-capital) — Seed, Series B
- Smedvig Capital (https://capitalatlas.ai/funds/smedvig-capital) — Series A, Series B
- Triple Point Investment Management (https://capitalatlas.ai/funds/triple-point-investment-management) — Series A
- Mercia Asset Management (https://capitalatlas.ai/funds/mercia-asset-management) — Series B, Series C
- Octopus Investments (https://capitalatlas.ai/funds/octopus-investments) — Series B, Series C
- Partech Partners (https://capitalatlas.ai/funds/partech-partners) — Series C
- Revaia (https://capitalatlas.ai/funds/revaia) — Series C